Skip to main content

FAU bioengineer receives NIH grant for novel biodegradable stent for esophageal cancer

Esophageal cancer is the eighth most common form of cancer worldwide and treatment of this disease continues to be a major medical challenge. Despite improvements in surgical techniques, 50 to 60 percent of patients with esophageal cancer are not suitable for surgery, because of late tumor detection or metastases that cannot be removed with surgery.
http://www.sciencecodex.com/fau_bioengineer_receives_nih_grant_for_novel_biodegradable_stent_for_esophageal_cancer-173676

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino